These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18560230)

  • 41. Voriconazole in an infant with cryptococcal meningitis.
    Shen YZ; Wang JR; Lu HZ
    Chin Med J (Engl); 2008 Feb; 121(3):286-8. PubMed ID: 18298929
    [No Abstract]   [Full Text] [Related]  

  • 42. Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
    Shoai Tehrani M; Sicre de Fontbrune F; Roth P; Allisy C; Bougnoux ME; Hermine O; Lecuit M; Lortholary O; Charlier C
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1094-5. PubMed ID: 23165463
    [No Abstract]   [Full Text] [Related]  

  • 43. Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
    Vandecasteele SJ; Van Wijngaerden E; Peetermans WE
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):656-7. PubMed ID: 15248093
    [No Abstract]   [Full Text] [Related]  

  • 44. Pseudoporphyria induced by voriconazole.
    Sharp MT; Horn TD
    J Am Acad Dermatol; 2005 Aug; 53(2):341-5. PubMed ID: 16021136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Seilmaier M; Hecht A; Guggemos W; Rüdisser K
    Med Klin (Munich); 2009 Jan; 104(1):58-62. PubMed ID: 19142596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hallucinations during voriconazole therapy.
    Zonios DI; Gea-Banacloche J; Childs R; Bennett JE
    Clin Infect Dis; 2008 Jul; 47(1):e7-e10. PubMed ID: 18491963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S; Adel N; Jurcic J
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voriconazole-induced pseudoporphyria.
    Tolland JP; McKeown PP; Corbett JR
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):29-31. PubMed ID: 17254033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Narendran N; Balasubramaniam B; Johnson E; Dick A; Mayer E
    Acta Ophthalmol; 2008 Aug; 86(5):525-32. PubMed ID: 18752527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracameral voriconazole: in vitro safety for human ocular cells.
    Kernt M; Kampik A
    Toxicology; 2009 Apr; 258(2-3):84-93. PubMed ID: 19428927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudoporphyria associated with voriconazole.
    Kwong WT; Hsu S
    J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Takemoto K; Yamamoto Y; Ueda Y; Kanazawa K; Yoshida K; Niki Y
    Chemotherapy; 2009; 55(2):105-13. PubMed ID: 19151551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
    Matsumoto Y; Oh-I T; Nagai A; Ohyama F; Ooishi T; Tsuboi R
    J Dermatol; 2009 Feb; 36(2):98-102. PubMed ID: 19284454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
    Al-Badriyeh D; Liew D; Stewart K; Kong DC
    J Antimicrob Chemother; 2009 Jan; 63(1):197-208. PubMed ID: 19001450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
    Crespo G; Cervera C; Michelena J; Marco F; Moreno A; Navasa M
    Liver Transpl; 2008 Nov; 14(11):1671-4. PubMed ID: 18975277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
    Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution.
    Labelle AL; Hamor RE; Barger AM; Maddox CW; Breaux CB
    Vet Ophthalmol; 2009; 12(1):48-52. PubMed ID: 19152598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.